Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2025-12-31 @ 5:32 AM
Study NCT ID:
NCT01176968
Status:
COMPLETED
Last Update Posted:
2020-12-22
First Post:
2010-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A6141116
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None